ELRIG UK appoints Nick Clare to board as Vendor Strategy Work Group Lead

The European Laboratory Research & Innovation Group (ELRIG) UK today announced the appointment of Nick Clare to the ELRIG board. He will chair and lead the Vendor Strategy Work Group to help ensure the vendors’ perspectives and interests are represented within the ELRIG board.

ELRIG aims to bring the life science and drug discovery communities accessible, high-quality scientific content and events with the support of its vendors. The board is comprised of a diverse group of individuals, representing all facets of the ELRIG community, as well as having the skills and experience needed to manage a learned society. This includes commercial representation within its governance structure to ensure its strategy is aligned with the needs of the vendor community.

Nick has two decades of industrial life science experience across a variety of scientific and commercial roles in large pharma and startups. He is currently Regional Sales Manager (Head of Europe) at Synthego and in recent years, he has supported scientists in selecting tools and workflows in stem cells and CRISPR applications to help drive the discovery of new treatments. Nick was elected to sit on the General Committee of ELRIG in 2021 to support the organisation’s Networking Work Group. Prior to this, Nick worked as a scientist and lab head in R&D, leading projects to establish cell/genetic models for drug discovery and disease modelling.

I appreciate the quality of science available through ELRIG; it is free to access and enables us all to grow together. I want to bring a stronger voice on behalf of the vendor by helping them to provide their expertise and share different ways of thinking about science, while continuing to support ELRIG’s events. The more we collaborate with the vendors, the more we can enable the drug discovery community to progress therapeutic candidates through to the clinic.”

Nick Clare, Vendor Strategy Work Group Leader at ELRIG UK and Regional Sales Manager at Synthego

Melanie Leveridge, Chair of ELRIG UK, and Head of Screening, Profiling and Mechanistic Biology, and Global Compound Management at GSK, said: “Nick’s experience, both in his day job at Synthego and from his involvement with our Networking Work Group, make him an excellent candidate to take on this role. With his help, we aim to better align ELRIG’s strategy with the needs of the vendor community, and ensure our scientific programme is well-connected with the exhibitors at our events.”

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    ELRIG (UK) Ltd.. (2023, May 11). ELRIG UK appoints Nick Clare to board as Vendor Strategy Work Group Lead. News-Medical. Retrieved on June 15, 2024 from https://www.news-medical.net/news/20230511/ELRIG-UK-appoints-Nick-Clare-to-board-as-Vendor-Strategy-Work-Group-Lead.aspx.

  • MLA

    ELRIG (UK) Ltd.. "ELRIG UK appoints Nick Clare to board as Vendor Strategy Work Group Lead". News-Medical. 15 June 2024. <https://www.news-medical.net/news/20230511/ELRIG-UK-appoints-Nick-Clare-to-board-as-Vendor-Strategy-Work-Group-Lead.aspx>.

  • Chicago

    ELRIG (UK) Ltd.. "ELRIG UK appoints Nick Clare to board as Vendor Strategy Work Group Lead". News-Medical. https://www.news-medical.net/news/20230511/ELRIG-UK-appoints-Nick-Clare-to-board-as-Vendor-Strategy-Work-Group-Lead.aspx. (accessed June 15, 2024).

  • Harvard

    ELRIG (UK) Ltd.. 2023. ELRIG UK appoints Nick Clare to board as Vendor Strategy Work Group Lead. News-Medical, viewed 15 June 2024, https://www.news-medical.net/news/20230511/ELRIG-UK-appoints-Nick-Clare-to-board-as-Vendor-Strategy-Work-Group-Lead.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
ELRIG UK announces Steve Bates and Dr Anderson Ryan as keynote speakers at Research and Innovation 2024